Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,28119,300 of 20,252 grants

Active NON-SBIR/STTR RPGS
Developing novel polytherapies for Non-Clear Cell Renal Cell Carcinoma
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2027

PROJECT SUMMARY: Developing novel polytherapies for Non-Clear Cell Renal Carcinoma Non-clear cell renal cell carcinoma (NCCRCC) is the therapeutic outlier in kidney cancer because...

$3.84M
USD
Active NON-SBIR/STTR RPGS
Novel inhibitor for oncogenic RAS for lung cancer
NATIONAL CANCER INSTITUTE Auburn University At Auburn United States 2021 – 2026

Project Summary/Abstract: Aberrant activation of RAS signaling is a major driver of lung cancer resulting from gain-in-function mutations in RAS genes often caused by tobacco-deriv...

$3.6M
USD
Completed NON-SBIR/STTR RPGS
Elucidating a Novel Mechanism for LATS1/2 in Suppressing Tumorigenesis
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2021 – 2026

Abstract: The Hippo pathway is an evolutionarily conserved signaling cascade regulating numerous biological processes, including cell growth and fate decision, organ size control,...

$2.49M
USD
Active NON-SBIR/STTR RPGS
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2026

PROJECT SUMMARY Most children treated for cancer in the US will achieve long-term survival, and survivorship presents unique challenges for this growing population. Pediatric brain...

$12.95M
USD
Active NON-SBIR/STTR RPGS
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2026

PROJECT SUMMARY Most children treated for cancer in the US will achieve long-term survival, and survivorship presents unique challenges for this growing population. Pediatric brain...

$1.16M
USD
Completed NON-SBIR/STTR RPGS
A sequential therapeutic strategy of senescence induction and senolytics for elimination of surviving residual breast tumor cells
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2021 – 2026

Abstract/Summary Chemotherapy and radiation can induce breast tumors to enter a prolonged state of growth arrest with characteristics of senescence. A senescent-like state is also...

$459.3K
USD
Completed NON-SBIR/STTR RPGS
ROS-induced SPIO Targeted Platform for Transarterial Liver Cancer Therapy
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2023

Title: SPIO-GOx conjugate for transarterial liver cancer therapy Abstract: Hepatocellular carcinoma (HCC) is the sixth most common malignancy worldwide and ranks third amongst canc...

$1.8M
USD
Completed NON-SBIR/STTR RPGS
Extracorporeal Filtration of Thermosensitive Liposomes
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT This project will develop a device and perform proof-of-concept studies in a rodent tumor model. The device will remove the chemotherapy agent Doxorubicin...

$2.11M
USD
Completed SBIR-STTR RPGS
Engineered adipokine receptor inhibitor for the treatment of triple negative breast cancer in obese patients
NATIONAL CANCER INSTITUTE Arrevus, Inc United States 2021 – 2023

PROJECT SUMMARY An estimated 1 million cases of breast cancer (BC) are diagnosed annually worldwide. Of these, approximately 170,000 are triple-negative (ER-/PR-/HER2-) breast canc...

$4M
USD
Completed TRAINING, INDIVIDUAL
Development of Small Molecule Inhibitor of PELP1 for Treating Advanced Breast Cancer
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT: Breast cancer (BC) is the most prevalent and second most lethal malignancy in females.Development of novel effective therapies for patients with therapy-r...

$352.6K
USD
Completed TRAINING, INDIVIDUAL
Impact of the Breast Cancer Immune Microenvironment on Racial Disparities and Survivorship
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2023

PROJECT SUMMARY Breast cancer (BC) is the most commonly diagnosed malignancy and second leading cause of cancer-related deaths among women in the US.Among all BC cases, black women...

$371K
USD
Completed TRAINING, INDIVIDUAL
Development of a combined ARFI/SWEI ultrasound elasticity imaging system for targeted prostate biopsy guidance
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2024

ABSTRACT Prostate cancer is the most common cancer among men in the United States, and early detection is crucial for effective treatment or management.Following an initial screeni...

$378.8K
USD
Completed NON-SBIR/STTR RPGS
Neoadjuvant Immunotherapy with Intratumoral CPG and PD-1 Blockade in Melanoma
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2026

PROJECT SUMMARY ABSTRACT High-risk resectable melanoma patients (MPs) with clinically detectable stage III with or without in-transit metastases have high-risk relapse1.Neoadjuvant...

$5.52M
USD
Completed TRAINING, INDIVIDUAL
Cancer cell state interactions with immune populations of the tumor microenvironment
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2021 – 2025

SUMMARY Tumors are complex systems composed of genetically and transcriptionally heterogeneous cells, and this variation has been implicated as a cause of drug resistance and morta...

$510.4K
USD
Completed NON-SBIR/STTR RPGS
A novel strategy to overcome drug resistance in cancer
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2021 – 2026

ABSTRACT The major obstacle to successful cancer therapy is the rapid development of drug resistance.While targeted therapies often extend overall survival in the subset of patient...

$4.97M
USD
Active NON-SBIR/STTR RPGS
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2026

PROJECT SUMMARY Most children treated for cancer in the US will achieve long-term survival, and survivorship presents unique challenges for this growing population.Pediatric brain...

$14.07M
USD
Completed TRAINING, INDIVIDUAL
Cervical cancer in Botswana: Identifying demographic, clinical and geographical features
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2021

The World Health Organization estimates that there were 570,000 cervical cancer cases and 311,000 cervical cancer deaths in 2018. In Botswana, cervical cancer is the most commonly...

$299.5K
USD
Completed SBIR-STTR RPGS
Rapid Breast Cancer Diagnosis in Low and Middle Income Countries
NATIONAL CANCER INSTITUTE Aikili Biosystems Inc United States 2021 – 2024

One of the biggest cancer challenges in low- and middle-income countries (LMICs) is the lack of access to accurate and affordable cellular and molecular diagnostics, which are esse...

$4M
USD
Completed TRAINING, INDIVIDUAL
The Role and Regulation of Monocarboxylate Transporters 1 and 4 in Epstein-Barr Virus-mediated B Lymphocyte Tumorigenesis
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2024

Epstein-Barr Virus (EBV) is a ubiquitous virus that establishes latency upon primary infection, but can hijack host metabolic pathways to promote tumorigenesis in immune-compromise...

$376.7K
USD
Completed NON-SBIR/STTR RPGS
Understanding PD-L1/L2 protein regulation, detection and signaling to predict melanoma therapeutic sensitivity
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT Modulators and effectors of anti-PD-1 responsiveness in cancer include T cell infiltration, an immune- suppressive microenvironment, tumor mutational burde...

$1.82M
USD